CRITKNOW

CRITKNOW

By Bharath Kumar Tirupakuzhi VijayaraghavanScienceMedicineHealth & FitnessLife Sciences
Download on the App Store

CRITKNOW episodes

  • Rethinking Critical Care Nephrology: John Kellum on TIGRIS, ICRAKI & the Future of ICU Kidney Care

    In this episode of Beyond the Data, we are joined by renowned critical care nephrology expert Prof. John Kellum for a discussion on two important recent trials: TIGRIS, evaluating polymyxin B haemoadsorption in septic shock, and ICRAKI, comparing intermittent haemodialysis with continuous renal replacement therapy in critically ill patients with AKI.

    We go beyond the trial results to explore the physiological rationale, methodological considerations, clinical implications and what these findings mean for the future of critical care nephrology.

    A thought-provoking conversation on interpreting evidence and translating it into better clinical decisions.

    49 min
  • The ICU Dialysis Debate Just Got a New Trial - Here's How to Read It

    In the first episode of Season 2, we discuss the recently published ICRAKI trial that compared intermittent vs. continuous renal replacement therapy for critically ill patients. We discuss the trial rationale and background, review the methods and results, and offer our critical interpretation. We also briefly discuss non-inferiority trial designs and the nuances involved in interpretation.


    Available on Apple, YouTube, Amazon, and Spotify.

    42 min
  • Bicarbonate for in-hospital cardiac arrest

    In this 10th episode of our podcast, we discuss the recently published BIHCA trial that evaluated sodium bicarbonate for in-hospital cardiac arrest. As always, we discuss the rationale, PICO, results, limitations and provide our interpretation and take-aways.


    Available on Apple, Spotify, and YouTube.


    If you have been enjoying, please comment, like, subscribe, and share!

    22 min
  • Beyond the Data: Middle Meningeal Artery Embolization

    In this BTD episode, we are joined by senior neurosurgeon and neuro-endovascular intervention specialist Dr. Srinivasan Paramasivam.

    We unpack the rationale, indications, and evolution of evidence behind middle meningeal artery embolization, along with key technical nuances, clinical decision-making, and real-world challenges.

    Listen to this episode alongside our discussion on the STEM trial for full context on the evolving evidence in chronic subdural hematoma management.

    Available on Apple, Spotify, Amazon, and YouTube.

    Remember to like, comment, subscribe, and share!

    31 min
  • Middle Meningeal Artery Embolization for Chronic SDH: STEM trial

    In this episode, we review the evidence on middle meningeal artery embolization for chronic subdural hematoma, with a deep dive into the STEM trial and a brief overview of other key studies. Alongside a critical appraisal of the clinical trials, we also include a short methods segment on stratification in the context of randomization.

    Our podcast is available on Apple, Spotify, and YouTube. If you are listening on Apple or Spotify, please note that the YouTube version includes images and text overlays that may further aid understanding of the trials discussed.

    If you have been enjoying our content, please like, comment, subscribe, and share!

    31 min
  • LOGICAL

    In this episode, we review the LOGICAL trial, which compared conservative versus liberal oxygenation targets in patients admitted to the ICU following cardiac arrest. We discuss the underlying rationale, summarize prior evidence, and examine the trial in detail. We also include a methods segment on response-adaptive randomization, before concluding with a discussion of the study’s strengths and limitations.

    Our podcast is available on Apple, Spotify, and YouTube.

    If you enjoy our content, please like, comment, and subscribe—it really helps us reach a wider audience. Thank you!

    38 min
  • SODa-BIC

    In this episode, we break down the recently published SODa-BIC trial, exploring the role of IV sodium bicarbonate in critically ill patients with metabolic acidemia. We walk through the rationale, prior evidence, PICO, results, and our key critiques and takeaways. We also include a short methods segment on adaptive sample size re-estimation.

    You can also find us on Apple Podcasts and Spotify.

    41 min
  • ARISE Fluids

    In this episode, we review the recently published ARISE-Fluids trial, which compared a restrictive fluid strategy with early vasopressor use against a more liberal fluid approach with delayed vasopressors. We place the trial in context, discuss the prior evidence, and unpack the key findings. We also use the study as a springboard to introduce “time-to-event” outcomes, before reflecting on the trial’s strengths and limitations.

    Our podcast is available on Apple, Spotify, and YouTube.

    You can also explore our methods blog at: ccmevidence.blog

    35 min
  • Beyond the Data: FAST

    In this 2nd episode of BTD, we speak with Dr. Nandini Sethuraman, Chief of Microbiology at the Apollo Central Reference Laboratory in Chennai. We discuss microbiology lab workflows, the different methods involved in species identification and susceptibility testing, common pitfalls, and also her take on the FAST trial!

    28 min
  • The FAST trial: Rapid vs. Standard AST

    In this episode, we discuss the FAST trial that compared a new and rapid antibiotic susceptibility test to standard practice. We discuss the rationale, trial design, the DOOR outcome framework and its analytical approach, and the limitations.

    37 min

About CRITKNOW

From the publisher's feed

Our take on the latest critical care evidence with deep insights on methods, interpretation, clinical relevance and so much more!

CRITKNOW is co-hosted by Bharath Kumar…